» Articles » PMID: 20190567

Bone Marrow-derived Mesenchymal Stem Cells Undergo JCV T-antigen Mediated Transformation and Generate Tumors with Neuroectodermal Characteristics

Overview
Specialties Oncology
Pharmacology
Date 2010 Mar 2
PMID 20190567
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

There is now accumulating evidence showing that some tumors may arise from transformed stem cells. In this study we demonstrate that adult bone marrow- derived mesenchymal stem cells (MSCs) undergo neoplastic transformation induced by the human polyomavirus JCV, early protein, T-antigen, and are tumorigenic when transplanted into the flanks of Nude mice as compared to non-transformed MSCs. Histologically, the tumors are heterogeneous with mesenchymal and neural crest characteristics as evidenced by expression of the neural crest markers p75, SOX-10, and S-100, with populations of tumor cells exhibiting characteristics of primitive neuroectodermal cells. In addition, a subset of T-antigen positive tumor cells exhibit a high proliferation index as detected by Ki-67 labeling, and co-express CD133, a marker which is expressed on cancer stem cells. These results show that tumors with neuroectodermal characteristics may arise from transformation of MSCs, a globally accessible adult stem cell with multipotent differentiation capacity. In light of earlier reports on the association of JCV with a broad variety of human tumors, our data suggests that T-antigen transformation of adult stem cells with a multipotent capacity can serve as a possible common origin for some of these cancers, and offers a novel model for oncogenesis.

Citing Articles

Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction model.

Tang Y, Gan X, Cheheltani R, Curran E, Lamberti G, Krynska B Nanomedicine. 2014; 10(8):1711-8.

PMID: 24941463 PMC: 4253977. DOI: 10.1016/j.nano.2014.06.001.


Immune surveillance and response to JC virus infection and PML.

Beltrami S, Gordon J J Neurovirol. 2013; 20(2):137-49.

PMID: 24297501 PMC: 3972311. DOI: 10.1007/s13365-013-0222-6.


Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen.

Gordon J, Sariyer I, De La Fuente-Granada M, Augelli B, Otte J, Azizi S PLoS One. 2013; 8(6):e65947.

PMID: 23805194 PMC: 3689770. DOI: 10.1371/journal.pone.0065947.


Novel polyomavirus associated with brain tumors in free-ranging raccoons, western United States.

Dela Cruz Jr F, Giannitti F, Li L, Woods L, Del Valle L, Delwart E Emerg Infect Dis. 2012; 19(1):77-84.

PMID: 23260029 PMC: 3558004. DOI: 10.3201/eid1901.121078.


In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrow.

Wislet-Gendebien S, Poulet C, Neirinckx V, Hennuy B, Swingland J, Laudet E PLoS One. 2012; 7(10):e46425.

PMID: 23071568 PMC: 3465331. DOI: 10.1371/journal.pone.0046425.

References
1.
Li H, Fan X, Kovi R, Jo Y, Moquin B, Konz R . Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res. 2007; 67(22):10889-98. DOI: 10.1158/0008-5472.CAN-07-2665. View

2.
Munoz-Elias G, Marcus A, Coyne T, Woodbury D, Black I . Adult bone marrow stromal cells in the embryonic brain: engraftment, migration, differentiation, and long-term survival. J Neurosci. 2004; 24(19):4585-95. PMC: 6729389. DOI: 10.1523/JNEUROSCI.5060-03.2004. View

3.
Krynska B, Otte J, FRANKS R, Khalili K, Croul S . Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene. 1999; 18(1):39-46. DOI: 10.1038/sj.onc.1202278. View

4.
Krynska B, Del Valle L, Gordon J, Otte J, Croul S, Khalili K . Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma. Virology. 2000; 274(1):65-74. DOI: 10.1006/viro.2000.0450. View

5.
Tso C, Shintaku P, Chen J, Liu Q, Liu J, Chen Z . Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res. 2006; 4(9):607-19. DOI: 10.1158/1541-7786.MCR-06-0005. View